AI Science Tracker
EN

Chest Hospital

1 discovery from 2026

Discoveries

Development and Validation of a Machine Learning Model for Predicting Three-Month Unplanned Readmission in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study.

Source check: Source checked. Not independent scientific confirmation.

Finding: Six models predicted 3-month unplanned readmission in 299 moderate-to-severe COPD patients; XGBoost validation AUC 0.809. Retrospective single-center split validation limits deployment claims. Testing: Six models predicted 3-month unplanned readmission in 299 moderate-to-severe COPD patients; XGBoost validation AUC 0.809. Retrospective single-center split validation limits deployment claims.. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.

Technology: Six models predicted 3-month unplanned readmission in 299 moderate-to-severe COPD patients; XGBoost validation AUC 0.809. Retrospective single-center split validation limits deployment claims.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Six models predicted 3-month unplanned readmission in 299 moderate-to-severe COPD patients; XGBoost validation AUC 0.809. Retrospective single-center split validation limits deployment claims.
Test and result
Six models predicted 3-month unplanned readmission in 299 moderate-to-severe COPD patients; XGBoost validation AUC 0.809. Retrospective single-center split validation limits deployment claims.
Limitation / still unknown
Six models predicted 3-month unplanned readmission in 299 moderate-to-severe COPD patients; XGBoost validation AUC 0.809. Retrospective single-center split validation limits deployment claims.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13724318/ · https://doi.org/10.2147/copd.s643657 · https://europepmc.org/article/MED/42973466

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.